Reciprocal Regulation between SIRT6 and miR-122 Controls Liver Metabolism and Predicts Hepatocarcinoma Prognosis

Cell Reports

Volumn 14, Issue 2, 2016, Pages 234-242

  Elhanati, Sivan ^a   Ben Hamo, Rotem ^a   Kanfi, Yariv ^a   Varvak, Alexander ^a   Glazz, Renana ^a   Lerrer, Batia ^a   Efroni, Sol ^a   Cohen, Haim Y ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Fatty acid oxidation; miR 122; SIRT6

Indexed keywords

HISTONE H3; MICRORNA 122; SIRTUIN 6; FATTY ACID; MICRORNA; MIRN122 MICRORNA, HUMAN; SIRT6 PROTEIN, HUMAN; SIRTUIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CANCER PROGNOSIS; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; FATTY ACID OXIDATION; GENE CONTROL; GENE EXPRESSION REGULATION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; ANIMAL; GENETICS; LIVER; LIVER TUMOR; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PROGNOSIS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; FATTY ACIDS; HUMANS; LIVER; LIVER NEOPLASMS; MICE; MICRORNAS; OXIDATION-REDUCTION; PROGNOSIS; SIRTUINS;

EID: 84955337844     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.12.023     Document Type: Article

References (40)

1. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Ben-Hamo R., Efroni S. MicroRNA-gene association as a prognostic biomarker in cancer exposes disease mechanisms. PLoS Comput. Biol. 2013, 9:e1003351.
4. Bhattacharyya S.N., Habermacher R., Martine U., Closs E.I., Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125:1111-1124.
5. Burchard J., Zhang C., Liu A.M., Poon R.T., Lee N.P., Wong K.F., Sham P.C., Lam B.Y., Ferguson M.D., Tokiwa G., et al. microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol. Syst. Biol. 2010, 6:402.
6. Chang J., Nicolas E., Marks D., Sander C., Lerro A., Buendia M.A., Xu C., Mason W.S., Moloshok T., Bort R., et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2004, 1:106-113.
7. Coulouarn C., Factor V.M., Andersen J.B., Durkin M.E., Thorgeirsson S.S. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009, 28:3526-3536.
8. Dávalos A., Goedeke L., Smibert P., Ramírez C.M., Warrier N.P., Andreo U., Cirera-Salinas D., Rayner K., Suresh U., Pastor-Pareja J.C., et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl. Acad. Sci. USA 2011, 108:9232-9237.
9. Elhanati S., Kanfi Y., Varvak A., Roichman A., Carmel-Gross I., Barth S., Gibor G., Cohen H.Y. Multiple regulatory layers of SREBP1/2 by SIRT6. Cell Rep. 2013, 4:905-912.
10. Elmén J., Lindow M., Schütz S., Lawrence M., Petri A., Obad S., Lindholm M., Hedtjärn M., Hansen H.F., Berger U., et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452:896-899.
11. Elmén J., Lindow M., Silahtaroglu A., Bak M., Christensen M., Lind-Thomsen A., Hedtjärn M., Hansen J.B., Hansen H.F., Straarup E.M., et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 2008, 36:1153-1162.
12. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., Watts L., Booten S.L., Graham M., McKay R., et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006, 3:87-98.
13. Feldstein O., Ben-Hamo R., Bashari D., Efroni S., Ginsberg D. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation. Mol. Cancer Res. 2012, 10:1169-1177.
14. Hanin G., Shenhar-Tsarfaty S., Yayon N., Yau Y.H., Bennett E.R., Sklan E.H., Rao D.C., Rankinen T., Bouchard C., Geifman-Shochat S., et al. Competing targets of microRNA-608 affect anxiety and hypertension. Hum. Mol. Genet. 2014, 23:4569-4580.
15. Holzenberger M., Dupont J., Ducos B., Leneuve P., Géloën A., Even P.C., Cervera P., Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421:182-187.
16. Hsu S.H., Wang B., Kota J., Yu J., Costinean S., Kutay H., Yu L., Bai S., La Perle K., Chivukula R.R., et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J. Clin. Invest. 2012, 122:2871-2883.
17. Jopling C. Liver-specific microRNA-122: Biogenesis and function. RNA Biol. 2012, 9:137-142.
18. Kaeberlein M., McVey M., Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999, 13:2570-2580.
19. Kanfi Y., Shalman R., Peshti V., Pilosof S.N., Gozlan Y.M., Pearson K.J., Lerrer B., Moazed D., Marine J.C., de Cabo R., Cohen H.Y. Regulation of SIRT6 protein levels by nutrient availability. FEBS Lett. 2008, 582:543-548.
20. Kanfi Y., Peshti V., Gil R., Naiman S., Nahum L., Levin E., Kronfeld-Schor N., Cohen H.Y. SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 2010, 9:162-173.
21. Kanfi Y., Naiman S., Amir G., Peshti V., Zinman G., Nahum L., Bar-Joseph Z., Cohen H.Y. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012, 483:218-221.
22. Kim H.S., Xiao C., Wang R.H., Lahusen T., Xu X., Vassilopoulos A., Vazquez-Ortiz G., Jeong W.I., Park O., Ki S.H., et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 2010, 12:224-236.
23. Krützfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
24. Li Z.Y., Xi Y., Zhu W.N., Zeng C., Zhang Z.Q., Guo Z.C., Hao D.L., Liu G., Feng L., Chen H.Z., et al. Positive regulation of hepatic miR-122 expression by HNF4α. J. Hepatol. 2011, 55:602-611.
25. Lorenzini A., Salmon A.B., Lerner C., Torres C., Ikeno Y., Motch S., McCarter R., Sell C. Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69:410-419.
26. Luna J.M., Scheel T.K., Danino T., Shaw K.S., Mele A., Fak J.J., Nishiuchi E., Takacs C.N., Catanese M.T., de Jong Y.P., et al. Hepatitis C virus RNA functionally sequesters miR-122. Cell 2015, 160:1099-1110.
27. Marquardt J.U., Fischer K., Baus K., Kashyap A., Ma S., Krupp M., Linke M., Teufel A., Zechner U., Strand D., et al. Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients. Hepatology 2013, 58:1054-1064.
28. Menon B., Sinden J., Franzo-Romain M., Botta R.B., Menon K.M. Regulation of LH receptor mRNA binding protein by miR-122 in rat ovaries. Endocrinology 2013, 154:4826-4834.
29. Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H., Damian M., Cheung P., Kusumoto R., Kawahara T.L., Barrett J.C., et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008, 452:492-496.
30. Michishita E., McCord R.A., Boxer L.D., Barber M.F., Hong T., Gozani O., Chua K.F. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 2009, 8:2664-2666.
31. Min L., Ji Y., Bakiri L., Qiu Z., Cen J., Chen X., Chen L., Scheuch H., Zheng H., Qin L., et al. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell Biol. 2012, 14:1203-1211.
32. Mostoslavsky R., Chua K.F., Lombard D.B., Pang W.W., Fischer M.R., Gellon L., Liu P., Mostoslavsky G., Franco S., Murphy M.M., et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006, 124:315-329.
33. Rogina B., Helfand S.L. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. USA 2004, 101:15998-16003.
34. Sebastián C., Zwaans B.M., Silberman D.M., Gymrek M., Goren A., Zhong L., Ram O., Truelove J., Guimaraes A.R., Toiber D., et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 2012, 151:1185-1199.
35. Sharma A., Diecke S., Zhang W.Y., Lan F., He C., Mordwinkin N.M., Chua K.F., Wu J.C. The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells. J. Biol. Chem. 2013, 288:18439-18447.
36. Tissenbaum H.A., Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001, 410:227-230.
37. Tsai W.C., Hsu S.D., Hsu C.S., Lai T.C., Chen S.J., Shen R., Huang Y., Chen H.C., Lee C.H., Tsai T.F., et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 2012, 122:2884-2897.
38. Wu X., Wu S., Tong L., Luan T., Lin L., Lu S., Zhao W., Ma Q., Liu H., Zhong Z. miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells. Scand. J. Gastroenterol. 2009, 44:1332-1339.
39. Yang B., Zwaans B.M., Eckersdorff M., Lombard D.B. The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability. Cell Cycle 2009, 8:2662-2663.
40. Zhong L., D'Urso A., Toiber D., Sebastian C., Henry R.E., Vadysirisack D.D., Guimaraes A., Marinelli B., Wikstrom J.D., Nir T., et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010, 140:280-293.